MiR-382-5p, the primary microRNA species of miR-382, had an oncomiR role in breast cancer initiation and progression by directly targeting and repressing RERG, an estrogen-regulated RAS superfamily GTPase member, which had previously been implicated in regulating Ras/ERK signaling activation [21]. The gene discussed is MAPK1; the disease is breast carcinoma.